Dr Lal Pathlabs

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE600L01024
NSEID: LALPATHLAB
BSEID: 539524
View on NSE | View on BSE

INR

1,443.40

31.5 (2.23%)

BSENSE

Feb 06

BSE+NSE Vol: 2.06 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Thyrocare Tech.

Metropolis Healt

Indegene

Dr Lal Pathlabs

Vijaya Diagnost.

Krsnaa Diagnost.

Vimta Labs

Syngene Intl.

Poly Medicure

Suven Life Scie.

Nephrocare Healt

Why is Dr Lal Pathlabs Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of 12.89% and Operating profit at 15.70% over the last 5 years

Flat results in Dec 25

EPS(Q) Lowest at Rs 5.40

With ROE of 22.4, it has a Very Expensive valuation with a 10.1 Price to Book Value

The stock is trading at a fair value compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 2.98%, its profits have risen by 32.1% ; the PEG ratio of the company is 1.4

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Dr Lal Pathlabs for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Dr Lal Pathlabs

2.98%

0.11

26.50%

Sensex

7.07%

0.61

11.53%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.89%

EBIT Growth (5y)

15.70%

EBIT to Interest (avg)

18.64

Debt to EBITDA (avg)

0.42

Net Debt to Equity (avg)

-0.48

Sales to Capital Employed (avg)

1.10

Tax Ratio

19.52%

Dividend Payout Ratio

42.00%

Pledged Shares

Institutional Holding

39.50%

ROCE (avg)

60.59%

ROE (avg)

20.98%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

10.13

EV to EBIT

37.70

EV to EBITDA

30.13

EV to Capital Employed

18.55

EV to Sales

8.65

PEG Ratio

1.38

Dividend Yield

0.90%

ROCE (Latest)

47.69%

ROE (Latest)

22.38%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-1What is not working for the Company

EPS(Q)

Lowest at Rs 5.40

Loading Valuation Snapshot...

Here's what is not working for Dr Lal Pathlabs

Earnings per Share (EPS) - Quarterly

Lowest at Rs 5.40

in the last five quarters

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (Rs)